Authors
Latest:
Connecting People, Science, and RegulationPDA/FDA regulatory conference promotes a commitment to quality.
Latest:
Data Integrity: Getting Back to BasicsEnsuring data integrity involves effort on an individual and global basis.
Latest:
Ask the Expert: Studies for Extractables and LeachablesIn this episode of the Ask the Expert video series, Susan J. Schniepp, distinguished fellow at Regulatory Compliance Associates, talks to Piet Christiaens, PhD, scientific director, E&L expert at Nelson Labs, and Dennis Jenke, PhD, principal consultant for Nelson Labs and chief executive scientist, Triad Scientific Solutions, about extractables and leachables and the testing required for each.
Latest:
Defining Risk Assessment of Aseptic ProcessesSusan Schniepp, distinguished fellow at Regulatory Compliance Associates, discusses the assessment of risk in the processing of intravenous injectable drugs.
Latest:
Utilizing Run Rules for Effective Monitoring in ManufacturingSorendls/Getty ImagesTo maintain a state of control and comply with regulatory authorities, many pharmaceutical, biotech, and medical-device companies have adopted continued pro
Latest:
Innovations in Automation—High-Throughput Dynamic Light Scattering for Screening Biotherapeutic FormulationsThis article introduces the technology that powers automated HT–DLS and explores its practical applications in enhancing formulation stability investigations.
Latest:
The Benefits of Combining UHPLC-UV and MS for Peptide Impurity ProfilingDetermining a peptide’s purity is challenging because impurities are often structurally similar to each other and the API and can be present at very low concentrations. New approaches offer a solution.
Latest:
A Risk-Based Strategy for Implementing Disposables in a Commercial Manufacturing ProcessThe author explores a dual-supplier sourcing strategy for single-use products and its ability to mitigate business continuity risk.
Latest:
Applications of Surface Plasmon Resonance for Detection of Bispecific Antibody ActivitySurface plasmon resonance is helping define bispecific antibodies, the next-generation of biopharma therapeutics.
Latest:
Evolving to Meet Industry ChangesIn the development of biopharmaceuticals and pharmaceuticals, the line is blurring.
Latest:
Analysis of PEGylated Protein by Tetra Detection Size Exclusion ChromatographyReliably detecting low amounts of high molecular weight impurities during process development and characterization of biopharmaceutical products.
Latest:
Top Three Factors That Will Drive Biopharma in the FutureDespite the unpredictability of biopharma, key forces promise to shape the market over the next few years
Latest:
Nontuberculosis Mycobacterium Contamination of a Mammalian Cell Bioreactor ProcessThe authors present a case study identifying a contaminant.
Latest:
Are Biopharma Patents Poised on the Post-Grant Chopping Block?This article examines trends in biopharma post-grant patent review and projects what the future holds in store.
Latest:
Combining Microbioreactors and Advanced Statistical Techniques to Optimize a Platform Process for a New Host-Cell LineUse of a subspace model is a viable method to characterize process space variables and optimize process performance.
Latest:
Combining Microbioreactors and Advanced Statistical Techniques to Optimize a Platform Process for a New Host-Cell LineUse of a subspace model is a viable method to characterize process space variables and optimize process performance.
Latest:
Variable Pathlength Fiber-Optic Spectrophotometry for Protein Determination in Immunoglobulin ConcentratesThe authors evaluate the SoloVPE technique as a replacement for nitrogen-based protein determination.
